X4 Pharmaceuticals

XFOR

Valor de mercado US$ 257 mi

#	Nome	Posição	Valor negociado	Ações Variação	Variação na participação
1	1 Morgan Stanley New York	US$ 44,2 mi	-US$ 23,4 mil	-5.713	-0,1%
2	2 Fidelity Investments Boston, Massachusetts	US$ 38,9 mi	+US$ 895 mil	+218.257	+3%
3	3 Bain Capital Life Sciences Investors Boston, Massachusetts	US$ 37,2 mi	–	–	–
4	4 Perceptive Advisors New York	US$ 37 mi	+US$ 4,91 mi	+1.195.843	+18%
5	SVCM 5 Saturn V Capital Management Austin, Texas	US$ 32,6 mi	+US$ 2,12 mi	+516.697	+8%
6	EAM 6 Empery Asset Management New York	US$ 32,4 mi	-US$ 8,26 mi	-2.013.527	-23%
7	7 Deep Track Capital Greenwich, Connecticut	US$ 27,5 mi	-US$ 1,89 mi	-460.778	-7%
8	8 BlackRock New York	US$ 25,9 mi	+US$ 17,8 mi	+4.343.112	+358%
9	KCM 9 Kalehua Capital Management Dallas, Texas	US$ 17,4 mi	–	–	–
10	10 Vanguard Capital Management Malvern, Pennsylvania	US$ 17,4 mi	+US$ 895 mil	+218.247	+6%
11	11 NEA Management Company Timonium, Maryland	US$ 15,1 mi	–	–	–
12	RA 12 Rosalind Advisors Toronto, Ontario, Canada	US$ 15 mi	–	–	–
13	13 Braidwell Stamford, Connecticut	US$ 13,6 mi	-US$ 1,44 mi	-350.200	-11%
14	14 Blackstone Inc New York	US$ 12,5 mi	–	–	–
15	15 Trails Edge Capital Partners Atlanta, Georgia	US$ 12 mi	–	–	–
16	16 Nantahala Capital Management New Canaan, Connecticut	US$ 11,4 mi	–	–	–
17	17 BVF Inc San Francisco, California	US$ 10,4 mi	–	–	–
18	18 Geode Capital Management Boston, Massachusetts	US$ 9,8 mi	+US$ 4,75 mi	+1.158.321	+123%
19	19 VR Adviser New York	US$ 9,03 mi	+US$ 6,58 mi	+1.603.728	+485%
20	20 Samsara BioCapital Palo Alto, California	US$ 6,52 mi	-US$ 1,79 mi	-436.979	-24%
21	21 State Street Boston, Massachusetts	US$ 6,05 mi	+US$ 3,66 mi	+892.483	+221%
22	22 Woodline Partners San Francisco, California	US$ 4,68 mi	–	–	–
23	23 Goldman Sachs New York	US$ 4,28 mi	+US$ 141 mil	+34.402	+4%
24	24 Northern Trust Chicago, Illinois	US$ 3,05 mi	+US$ 1,95 mi	+474.614	+266%
25	25 Vanguard Fiduciary Trust Malvern, Pennsylvania	US$ 2,67 mi	+US$ 375 mil	+91.305	+19%

X4 Pharmaceuticals XFOR Valor de mercado US$ 257 mi

X4 Pharmaceuticals

XFOR

Valor de mercado US$ 257 mi